Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), today reported financial results for the second quarter ended Dec. 31, ...

David T., 42, describes himself as a "serial dieter.” He tried low-carb, keto, calorie-counting-each yielding modest result ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“ Cybin ” or the “ Company ”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

BioLogic Pharma Solutions aims to be the trusted partner for companies handling complex drug development and commercialization pathways.

The Penn Center for Innovation has enabled world-changing advancements, from mRNA vaccines to CAR T cancer treatments.

The key clinical benefits of this AI-based system include more accurate newborn resuscitation timelines, ensuring ...

The Jurassic World Rebirth looks to further transform the beloved franchise but also continues a trend that has remained ...

Insilico Medicine ( “Insilico”) , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today ...